The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)Kremlin: It is very important to ensure the safety of our bases and diplomatic missions.Light Media: "Nezha's Devil's Boy Makes a Sea" has rich derivatives planning. Light Media said on the interactive platform that at present, the company's IP derivative business is advancing normally. "Nezha's Devil Kids Roaring the Sea" has been planned and will launch derivative products with rich categories and wide price range in due course, including tide play, handcrafted products, statues, cards, stationery, food play, badges, billboards, publications, plush products and daily necessities, which can meet the diverse needs of different groups of people.
CITIC Bank: Redemption of open-ended capital bonds. CITIC Bank announced that from December 9 to December 11, 2019, it issued RMB 40 billion of open-ended capital bonds (hereinafter referred to as "current bonds"), and on December 12, 2019, it issued the Announcement of China CITIC Bank Corporation on the Completion of Issuance of Open-ended Capital Bonds. According to the relevant provisions of the prospectus of this issue, this issue has the issuer's conditional redemption right, and the issuer has the right to redeem this issue in whole or in part on the interest payment date of the fifth year of this issue, that is, December 11, 2024. As of the date of this announcement, with the approval of the State Financial Supervision and Administration, the Bank has exercised the right of redemption and redeemed the bonds in full.Kremlin: Many people predict that Biden's administration will try to leave a difficult legacy by escalating tensions with Russia.MONDELEZ's share price rose 2.5% before the market, and it was authorized to buy back $9 billion in the news.
3 Lianban Huifa Food: Zhenghechang Investment reduced its shareholding by 1 million shares today, and the reduction plan has not yet been completed. On November 8, 2024, the company disclosed the Announcement on Shareholder Reduction Plan of Huifa Food, and the shareholder Zhenghechang Investment Co., Ltd. plans to reduce its shareholding by centralized bidding, not exceeding 2,446,400 shares, not exceeding 1% of the company's total share capital; The reduction of holdings through block trading shall not exceed 4,892,800 shares, and shall not exceed 2% of the company's total share capital. The planned reduction period is from November 29, 2024 to February 27, 2025. On December 11th, 2024, Zhenghechang Investment Co., Ltd. reduced its shareholding by 1 million shares through centralized bidding. At present, the shareholder's shareholding reduction plan has not been completed.Health Yuan: Obtained the commitment letter of stock repurchase loan from financial institutions of no more than 238 million yuan. Health Yuan announcement, the company recently obtained the commitment letter of loan from Industrial Bank, with a loan amount of no more than 238 million yuan, no more than 90% of the upper limit of repurchase amount, and a loan period of no more than 36 months, which is specially used to repurchase shares of listed companies. The total amount of the company's actual loan and the amount of the repurchased funds shall not exceed the upper limit of the amount of this repurchase program. The commitment letter of the financial institution's stock repurchase loan obtained this time does not represent the company's commitment to the repurchase amount. The specific number of shares repurchased shall be subject to the actual number of shares repurchased at the expiration of the repurchase period.The personal pension fund will be expanded to broad-based index products, and the personal pension pilot will be fully liberalized in the near future, expanding from the original 36 pilot cities to the whole country. At the same time, personal pension fund products are also expanding, and some mature broad-based ETF-linked funds and broad-based index OTC products will add Y shares. It is reported that the investable products included in personal pension may include over-the-counter products tracking nearly 20 broad-based indexes such as Shanghai and Shenzhen 300 Index, CSI 500 Index, CSI 800 Index, GEM Index and Kechuang 50 Index. (21 Finance)
Strategy guide 12-13
Strategy guide
12-13
Strategy guide
12-13